MedPath

Buprenorphine Maintenance for Opioid Addicts - 2

Phase 2
Completed
Conditions
Opioid-Related Disorders
Registration Number
NCT00000203
Lead Sponsor
Yale University
Brief Summary

The purpose of this study is to evaluate varying doses of buprenorphine for opioid dependence and cocaine abuse.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Drug use
Psychological symptoms
Withdrawal symptoms
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

VA Connecticut Healthcare System

🇺🇸

New Haven, Connecticut, United States

VA Connecticut Healthcare System
🇺🇸New Haven, Connecticut, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.